MapLight Therapeutics, Inc. Payments to Acquire Investments
MapLight Therapeutics, Inc. (MPLT) reported Payments to Acquire Investments of $19.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-13
- MapLight Therapeutics, Inc. payments to acquire investments for the quarter ending 2025-12-31 was $266.18M.
- MapLight Therapeutics, Inc. payments to acquire investments for the quarter ending 2025-09-30 was $142.06M.
- MapLight Therapeutics, Inc. payments to acquire investments for the quarter ending 2024-12-31 was $0.00.
- MapLight Therapeutics, Inc. payments to acquire investments for fiscal 2025 was $408.23M, a 226.54% increase from fiscal 2024.
- MapLight Therapeutics, Inc. payments to acquire investments for fiscal 2024 was $125.02M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.77M 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $266.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $408.23M derived: sum of 2 quarters · filed 2026-03-26 | $408.23M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $142.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-12-04 | $142.06M 10-Q · filed 2025-12-04 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $125.02M 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $125.02M 10-Q · filed 2025-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |